1. "Molecular Imaging and Therapy Service"
  2. "Jason Lewis"
Formats
  1. Journal Article (73)
  2. Meeting Abstract (53)
  3. Editorial (1)
  4. Review (1)
Groups
  1. Center for Pancreatic Cancer Research (128)
  2. GSK Faculty (128)
  3. Molecular Imaging and Therapy Service (128)
  4. Radiochemistry and Imaging Sciences Service (128)
  5. Radiology, Department of (128)
  6. Sloan Kettering Institute Postdocs (80)

More Groups

People
  1. Jason Lewis (128)
  2. Serge Lyashchenko (61)
  3. Steven Larson (57)
  4. Neeta Pandit-Taskar (50)
  5. Pat Zanzonico (39)
  6. Jorge Carrasquillo (35)

More People

Years
  1. 2024 (1)
  2. 2023 (4)
  3. 2022 (6)
  4. 2021 (7)
  5. 2020 (13)
  6. 2019 (15)

More Years

Publications
  1. Journal of Nuclear Medicine (37)
  2. Journal of Clinical Oncology (18)
  3. Clinical Cancer Research (8)
  4. European Journal of Nuclear Medicine and Molecular Imaging (7)
  5. Neuro-Oncology (7)
  6. Pediatric Blood and Cancer (6)

More Publications

Publishers
  1. Society of Nuclear Medicine (37)
  2. American Society of Clinical Oncology (18)
  3. American Association for Cancer Research (16)
  4. Oxford University Press (9)
  5. Springer (9)
  6. Nature Publishing Group (6)

More Publishers

Results (128)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-in-human evaluation of site-specifically labeled (89)Zr-pertuzumab in patients with HER2-positive breast cancer
    Journal Article

    Yeh, R.; O'Donoghue, J. A.; Jayaprakasam, V. S.; Mauguen, A.; Min, R.; Park, S.; Brockway, J. P.; Bromberg, J. F.; Zhi, W. I.; Robson, M. E.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Detection of HER2-low lesions using HER2-targeted PET imaging in patients with HER2-negative metastatic breast cancer
    Meeting Abstract

    Yeh, R.; Lyashchenko, S. K.; Zeglis, B. M.; Lewis, J. S.; Ulaner, G. A.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Ambient light resistant shortwave infrared fluorescence imaging for preclinical tumor delineation via the pH low-insertion peptide conjugated to indocyanine green
    Journal Article

    Mc Larney, B. E.; Kim, M.; Roberts, S.; Skubal, M.; Hsu, H. T.; Ogirala, A.; Pratt, E. C.; Pillarsetty, N. V. K.; Heller, D. A.; Lewis, J. S.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) in esophagogastric cancer using (89)Zr-trastuzumab PET: A pilot study
    Journal Article

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Chou, J. F.; Capanu, M.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Lyashchenko, S. K.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Meeting Abstract

    Modak, S.; Pandit Taskar, N.; Kushner, B.; Zanzonico, P.; Humm, J.; Donzelli, M.; Lewis, J.; Lyashchenko, S.; Chu, B.; Larson, S.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Journal Article

    Kramer, K.; Pandit-Taskar, N.; Kushner, B. H.; Zanzonico, P.; Humm, J. L.; Tomlinson, U.; Donzelli, M.; Wolden, S. L.; Haque, S.; Dunkel, I.; more...
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Long-term survival from a phase 1 doseescalation trial using convection-enhanced delivery (CED) of radioimmunotherapeutic (124)I-omburtamab for treatment of diffuse intrinsic pontine glioma (DIPG)
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Tasker, N.; Haque, S.; Zanzonico, P.; Carrasquillo, J.; Lyashchenko, S. K.; Thakur, S. B.; Khakoo, Y.; Dunkel, I. J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Feasibility, safety, and biodistribution of 18F-BMS-986229 PET in patients with esophagogastric (EG) cancer
    Meeting Abstract

    Cytryn, S.; Lumish, M.; Paroder, V.; Philemond, S.; Lewis, J.; Lyashchenko, S.; Janjigian, Y.; Pandit-Taskar, N.
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Radiotheranostics in oncology: Current challenges and emerging opportunities
    Review

    Bodei, L.; Herrmann, K.; Schòˆder, H.; Scott, A. M.; Lewis, J. S.
    Nature Reviews Clinical Oncology (2022)

    Fulltext@MSK | Save